Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2011

01-01-2011 | Breast Oncology

Cancer Genome Explosion and Systems Biology: Impact on Surgical Oncology?

Author: Dimitrios H. Roukos, MD, PhD

Published in: Annals of Surgical Oncology | Issue 1/2011

Login to get access

Excerpt

Each human being and each cancer patient is unique. Based on this assessment provided by the current personal genomics revolution, the emerging conceptual design is great. By identifying the genetics, genomics, and epigenomics variants underlying cancer phenotype, we would move forward toward improving surgical oncology. A decade after the first draft of human full-genome sequence, what is the progress of “big” biology and science? How do these advances influence surgical oncology and what are the challenges to overcome in order to achieve a dramatic improvement in the personalized prevention and treatment of solid cancer? …
Literature
1.
The human genome at ten. Nature. 2010;464:649–50.
2.
3.
Check HE. Human genome at ten: life is complicated. Nature. 2010;464:664–7.CrossRef
4.
Roukos DH. Systems medicine: a real approach for future personalized oncology? Pharmacogenomics. 2010;11:283–7.CrossRefPubMed
5.
Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009;461:218–23.CrossRefPubMed
6.
7.
8.
Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:192–9.PubMed
9.
Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10:247–50.CrossRefPubMed
10.
Roukos DH. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn. 2010;10:33–48.CrossRefPubMed
Metadata
Title
Cancer Genome Explosion and Systems Biology: Impact on Surgical Oncology?
Author
Dimitrios H. Roukos, MD, PhD
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 1/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1355-y

Other articles of this Issue 1/2011

Annals of Surgical Oncology 1/2011 Go to the issue

Breast Oncology

Alternative Approaches for Oncoplastic Breast Surgery

Gynecologic Oncology

Prognostic Factors of a Large Retrospective Series of Mucinous Borderline Tumors of the Ovary (Excluding Peritoneal Pseudomyxoma)

Gastrointestinal Oncology

Severe Electrolyte Disturbances After Hyperthermic Intraperitoneal Chemotherapy: Oxaliplatin Versus Mitomycin C

Gastrointestinal Oncology

In Reply: Pseudomyxoma Peritonei: Debulk or Maximal Cytoreduction?

Healthcare Policy and Outcomes

Improving on National Quality Indicators of Breast Cancer Care in a Large Public Hospital as a Means to Decrease Disparities for African American Women

Endocrine Tumors

Surgeon-Performed Ultrasound Can Predict Differentiated Thyroid Cancer in Patients with Solitary Thyroid Nodules